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Background: Anaplasma phagocytophilum is an intracellular organism in the Order Rickettsiales that infects diverse
animal species and is causing an emerging disease in humans, dogs and horses. Different strains have very different
cell tropisms and virulence. For example, in the U.S., strains have been described that infect ruminants but not dogs
or rodents. An intriguing question is how the strains of A. phagocytophilum differ and what different genome loci
are involved in cell tropisms and/or virulence. Type IV secretion systems (T4SS) are responsible for translocation of
substrates across the cell membrane by mechanisms that require contact with the recipient cell. They are especially
important in organisms such as the Rickettsiales which require T4SS to aid colonization and survival within both
mammalian and tick vector cells. We determined the structure of the T4SS in 7 strains from the U.S. and Europe
and revised the sequence of the repetitive virB6 locus of the human HZ strain.
Results: Although in all strains the T4SS conforms to the previously described split loci for vir genes, there is great
diversity within these loci among strains. This is particularly evident in the virB2 and virB6 which are postulated to
encode the secretion channel and proteins exposed on the bacterial surface. VirB6-4 has an unusual highly
repetitive structure and can have a molecular weight greater than 500,000. For many of the virs, phylogenetic trees
position A. phagocytophilum strains infecting ruminants in the U.S. and Europe distant from strains infecting
humans and dogs in the U.S.
Conclusions: Our study reveals evidence of gene duplication and considerable diversity of T4SS components in
strains infecting different animals. The diversity in virB2 is in both the total number of copies, which varied from 8
to 15 in the herein characterized strains, and in the sequence of each copy. The diversity in virB6 is in the sequence
of each of the 4 copies in the single locus and the presence of varying numbers of repetitive units in virB6-3 and
virB6-4. These data suggest that the T4SS should be investigated further for a potential role in strain virulence of A.
phagocytophilum.
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Anaplasma phagocytophilum is a tick-borne pathogen in
the Order Rickettsiales that is increasingly recognized as
a cause of disease in humans and animals world-wide
[1,2]. It causes the potentially fatal disease of human
granulocytic anaplasmosis, which typically manifests as a
flu-like illness accompanied by leukopenia, thrombo-
cytopenia and anemia. It was initially recognized in the
early 1990's when patients from Wisconsin and Minnesota* Correspondence: barbet@ufl.edu
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distribution, and reproduction in any mediumdeveloped febrile illness following a tick bite [3]. Since that
time the number of human cases has increased annually;
between 2000 and 2007 the reported incidence in the U.S.
increased from 1.4 to 3.0 cases/million persons/year [4].
The case fatality rate was 0.6% and the hospitalization
rate was 36%. In Massachusetts during the 2009 trans-
mission season there were 33 confirmed cases with 14
(42%) requiring hospitalization [5]. The human disease is
also present in Europe and Asia [2]. A recent study of 83
A. phagocytophilum-infected patients in China reported
a mortality rate in this cohort of 26.5% [6]. In the U.S.,
there has been a parallel increase in cases of the disease
[7] and seroprevalence [8] in dogs in the eastern andtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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are Ixodes scapularis and Ixodes pacificus and wild
rodents are the main reservoirs of human infections.
A. phagocytophilum also infects numerous other mam-
malian species including ruminants, horses, cats, and
bears and the symptoms are extremely variable, with
some mammalian species exhibiting acute disease and
others only persistent asymptomatic infections [9,10].
For example, A. phagocytophilum strains isolated from
deer in the U.S. can have a slightly different 16S
rRNA sequence and be uninfective to mice and it is
thought, humans [11-13]. In Europe, this agent has been
known to cause disease of ruminants for >100 years, yet
there have been few human infections [14]. The genome
sequence is available for a single strain of A. phagocyto-
philum derived from an infected human in the U.S. and
it is apparent that, although this strain lacks Type II, III,
V and VI secretion systems, a Type IV secretion system
(T4SS) is present [15]. As in other members of the
Rickettsiales, the T4SS of A. phagocytophilum is organized
differently from most gram-negative bacteria with the
component vir genes distributed between three major
genome locations [16].
The T4SS typically encodes a membrane-spanning
multiprotein complex that forms a transmembrane
channel through which solutes can pass into host cells.
It can mediate transfer of DNA and proteins into
eukaryotic host cells, interfere with host signaling, and is
essential for the survival of intracellular bacteria [17]. In
A. phagocytophilum, which preferentially colonize neu-
trophilic white blood cells, it is thought that the T4SS
secretes virulence factors that are responsible for sub-
verting innate immunity and inhibiting host cell apop-
tosis [16]. Interestingly, there appears to be differential
transcription of the T4SS in ticks and in the mammalian
host with virB6 and virB9 upregulated during infection
of human neutrophils and different virB2 paralogs
expressed in mammalian and tick cells [18]. There is evi-
dence that VirB2, VirB6 and VirB9 are exposed on the
outer membrane surface in the Rickettsiales [18-20],
which has stimulated interest in their potential use as
vaccine candidates. This possibility has been investigated
more extensively in the related organism Anaplasma
marginale [21-25]. In A. marginale, unlike many other
surface-exposed proteins, the T4SS proteins are con-
served between strains [26]. Also, cattle immunized with
outer membranes and protected against challenge infec-
tion respond with IgG and T cells to Vir proteins, not-
ably VirB2, VirB9 and VirB10. To date, only two T4SS
substrates have been identified and partially characterized
in A. phagocytophilum: the ankyrin repeat domain-
containing protein, AnkA, and the Anaplasma translo-
cated substrate 1, Ats-1. AnkA translocates to the host
nucleus and interacts with DNA [27,28], while Ats-1 isimported into the mitochondria where it is proposed to
interfere with the induction of apoptosis [29].
In this study, we compared the structure and diversity
of the T4SS in different strains of A. phagocytophilum
infecting humans, dogs, rodents and ruminants. Most
diversity was found in the proteins thought to be surface-
exposed, which may be associated with the different
virulence and cell invasion properties of this species.
Results and discussion
The vir loci were sequenced in eight strains of A. phago-
cytophilum; seven of these were strains for which previ-
ous structural information was not available and
included organisms originally isolated from U.S. dogs
(ApDog1, ApDog2), a rodent (ApJM), a horse (ApMRK),
the ruminant Ap variant 1 strain (ApVar1) and two
strains from Norwegian sheep (ApNorV1, ApNorV2).
The human HZ strain was also resequenced, as optical
mapping had suggested a possible error in the previously
sequenced virB6-4 locus. The data indicated consider-
able diversity in the individual vir loci between strains
that will be discussed below. In all strains, however, as
noted previously [20,30], the vir loci were distributed
mainly in three gene clusters comprising: virB8-1, virB9-
1, virB10, virB11 and virD4; virB20s and virB4-2; and
virB3, virB4-1, and the four virB6 paralogs (Figure 1).
These three loci may each be transcribed polycistroni-
cally [31], although it is clear that T4SS structure in the
Rickettsiales is unique and more complex than initially
thought. The number of virB2 paralogs was different be-
tween strains with the human HZ strain having the least
(8 total paralogs) and the ruminant strains having the
most (up to15 total paralogs). The description of the
T4SS components presented here follows the functional
classification described by Alvarez-Martinez and Christie
[20].
Inner membrane channel/scaffold subunits: VirB3, VirB6,
VirB8 and VirB10
The most conserved of these subunits are VirB3, VirB8
and VirB10, with few differences between strains. VirB3
has been linked in Agrobacterium tumefaciens with pilus
assembly and substrate translocation [32,33]. It is abso-
lutely conserved between strains with no amino acid
changes and conforms to the typical VirB3 structure.
Two alpha-helical domains for insertion into the cyto-
plasmic membrane are strongly predicted by TMpred.
VirB8, proposed to function as a nucleation factor dur-
ing the assembly of T4SS [34,35], is also well conserved,
particularly VirB8-1 in the polycistronic transcription
locus (one amino acid change between all strains).
VirB10, proposed to function as a scaffold across the
entire cell envelope [36], is also generally well-
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Figure 1 Distribution and content of vir gene clusters in eight diverse A. phagocytophilum strains. Top panel. Schematic representation of
all vir loci (colored arrows) showing the three conserved gene cluster islands (see text). VirB-7, virB8-2 and virB9-2 are not part of vir gene clusters,
but their location relative to surrounding genes is also highly conserved among strains. A small cluster comprising truncated (t) virB6 and virB4
gene fragments is present in all strains, but the Norwegian lamb strains have one additional virB4-t. Bottom panel. Magnification of the virB2 gene
cluster. Numbering of paralogs 1–8 is based on the original ApHZ annotated genome (GenBank CP000235). Artificial gaps (stippled lines) were
introduced to allow alignment of the more spatially conserved paralogs B2-1, 2–2 and 2–3 at one end, and B2-7 and 2–8 at the other end of the
cluster. With the exception of virB2-9, lacking in ApHZ, the number and arrangement (but not necessarily sequence) of virB2 genes is highly
conserved in all but the US ruminant ApVar-1 and ApNorLamb-V1, which have several additional virB2 genes. In both strains a sub-cluster of 6
distinct genes was present. Due to the repetitive nature of sequences in this region, combined with the relatively short length of 454 reads
(≤550 bp), their placement could not be confidently ascertained (highlighted by arrows and ‘?’). Maps are drawn to scale. Double lines designate
interruption in sequences. Genes belonging to the same grouping have the same color. oriC; origin of replication.
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with respect to ApHZ (data not shown). However, all A.
phagocytophilum VirB100s, including ApNorLamb-V1,
have two strongly predicted transmembrane domains,
which supports their function as membrane scaffolding
subunits in these organisms.
Of these inner membrane channel subunits, the data
on VirB6 are the most interesting. All VirB6 subunitsFigure 2 Phylogenetic tree to show the relationship of syntenic VirB6
is shown underneath representing the number of amino acid substitutionsthat have been described possess a highly hydrophobic
membrane domain including five or more predicted
transmembrane domains [20]. Some VirB6 proteins also
have an extended C-terminal hydrophilic domain that
has been proposed to protrude through the T4SS into
the target cell, or may be proteolytically released from
the N-terminal domain and then translocated into the
target cell. Evidence has been obtained for surfaceproteins from different strains of A. phagocytophilum. A scale bar
/site.
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Of all the membrane channel subunits, the most se-
quence diversity between A. phagocytophilum strains
was in the four VirB6 paralogs (Figure 1). Although
there were no amino acid changes in the VirB6-1, VirB6-
2 and VirB6-3 paralogs between human, dog and rodent
strains, the ruminant and horse strains had numerous
substitutions throughout each molecule, agreeing with
the closer evolutionary relationship between strains
infecting humans and dogs in the U.S. (Figure 2). Fur-
thermore, major differences in repeat number and se-
quence were found in the C-terminal repeat region of
VirB6-3 (yellow boxes in Figure 3A and Additional file 1:
Figure S1) in ruminant and horse strains, with the horse
strain showing the least variability from ApHZ.
The only amino acid differences detected between the
human, dog and rodent strains were in the VirB6-4 sub-
unit. VirB6-4 in these strains contains four repeat
regions (R1-R4 in Figure 3A) and variability in repeat


















































Figure 3 The 30 end of A. phagocytophilum virB6-4 genes is composed
dramatic variability among strains. A. Map of the human HZ strain virB6
repeat regions (R1-R4). The most variability occurred in R4; this region is 5.8
(CP000235). The original sequence is diagrammed above the map, with the
repeated R4 segments of 2.7 kb and 1.15 kb are indicated above. Vertical b
transmembrane domains. BamHI sites, of which there is one in all R4 type
of PCR primers used in C. B. BamHI genomic maps depicting the virB6-4 lo
each respective map. In the regions outside the virB6-4 locus, correspondin
map sizes were in good agreement with the actual sizes, except within R4
fragments <2 kb. Despite these discrepancies, the cumulative size of the g
agreement with that in the ApDog1 genome sequence. C. The variability in
diverse A. phagocytophilum strains.and R4 (Additional file 2: Figure S2). Within R1
(Figure 3A), the only difference detected was in ApDog2
which had 4 and 1 partial of 231 bp repeat units (data
not shown), compared to 3 and 1 partial repeats in the
ApDog1, ApJM and ApHZ virB6-4 R1. Optical mapping
of the Dog1 genome and comparison with ApHZ sug-
gested that the sequence obtained previously for the
human HZ strain virB6-4 was incorrect (Figure 3B). This
was confirmed by PCR and sequencing, and mapped
specifically to the 30-most R4 region (Figure 3C). Be-
cause of its size and unusual composition it was only
possible to resolve this sequence using the long read-
length Pacific Biosciences technology (see Methods).
The corrected virB6-4 R4 of ApHZ, totaling 6.89 kb, dif-
fered from the original by 5.88 kb of additional sequence
composed exclusively of 84 bp [type 1, a and b (T1a,
T1b); light/dark blue boxes, respectively, in Figure 3A]
and 162 bp [type 2, a and b (T2a, T2b); light/dark or-
ange boxes, respectively, in Figure 3A] repeat units, giv-


































































of an unusually large tandem repeat region, which exhibits
-3 and virB6-4 genes, highlighting the location and structure of several
8 kb larger than previously reported for the ApHZ genome
dashed line representing the segment missing in CP000235. Larger
lack bars within each gene designate segments encoding predicted
2 repeats (see Figure S2B), are indicated. Also shown are the positions
cus (black arrows).The segment encompassing R4 is highlighted below
g BamHI fragments are shown in the same color. Overall, the optical
. This is attributed to the limitation of optical mapping in resolving
enomic region encompassing virB6-4 in the optical map is in close
size of PCR products spanning virB6-4 repeat regions R4 and R3/R4 in
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original sequence. Further, the 50- and 30-most 2.7 kb of
this complex structure are identical in sequence, and the
30-most 1.15 kb of each of these segments is repeated
again in the center of R4 (Figure 3A and Additional file
2: Figure S2). Although the possibility exists that the
ApHZ population from which we isolated gDNA differs
within the virB6-4 R3/R4 repeat regions from the popu-
lation used to generate CP000235, the fact that all
strains investigated herein presented expansive R3/R4
regions (Figure 3C) would contradict that. Instead, it is
more plausible that the existence of 2.7 kb of identical
repeats at the ends of the ApHZ R4 may have lead to
the excision of most of its sequence during construc-
tion/propagation of those libraries. Interestingly, virB6-4
R3 and R4 were identical both in size and sequence in
the Dog1 and rodent strains despite differing markedly
from the HZ and Dog2 strain regions (Additional file 2:
Figure S2A). Within R3, these strains had 2 additional
405 bp repeats compared to ApHZ and one more com-
pared to the Dog2 strain. However, differences between
strains were most dramatic within R4. Not only was this
region in ApDog1/ApJM 2.87 kb larger than in ApHZ
bringing the total number of repeats to 81 and 1 partial,
but intriguingly, the repeat pattern was completely unre-
lated to that in the HZ strain. Also, the Dog1 and rodent
strain R4 lacked T1b repeat units, while having a third
type 2 repeat variant, namely T2c, which differed from
T2b by 1 SNP and a 12 bp deletion (Additional file 2:
Figure S2). Partial analysis of the ApDog2 454 reads
spanning R4 (estimated at ~8 kb by PCR; Figure 3C)
showed that the order of the 50- and 30-most three repeat
units differed from either the HZ or Dog1/rodent strain
R4 repeat patterns (Additional file 2: Figure S2A). Not-
ably, our preliminary analyses of the horse and ruminant
454 reads suggest the absence of distinct R3 and R4
regions in virB6-4 in these strains. Rather, the few repeat
units identified to date appear to be a combination of R3
and R4 repeats (data not shown). It is also unclear if the
~17 kb and ~25 kb PCR products generated with pri-
mers AB1393/1466 in ApVar-1 and ApNorLamb-V2, re-
spectively (Figure 3C), are composed mainly of repeats,
or alternatively if a fifth virB-6 gene paralog exists in
these strains. Taken together, the data presented here
clearly demonstrate the extreme variability of the T4SS
VirB6-4 subunit among A. phagocytophilum strains. Al-
though the differences between the more closely related
human, dog and rodent US strains were mainly within
repeat-laden regions, the fact that an extensive, distinct
repeat pattern was maintained in two strains would
speak against the possibility that the variability may be
attributed solely to the highly recombinogenic nature of
such structures. Worth noting, Camp Ripley, where the
infected jumping mouse was captured (2001) is only ~20miles away from the city of Baxter, MN, where Dog1
resides. Although there are no records of where this dog
may have actually acquired the infection, it presented
with severe clinical disease in 2007.
The unusual structure and likely antigenicity of the
C-terminal region of the A. phagocytophilum VirB6-40s is
apparent in hydrophobicity plots (Figure 4). What spe-
cific properties these distinct repeat patterns may confer
onto each strain awaits functional analysis of these pro-
teins in A. phagocytophilum. The corrected VirB6-4
translated protein had a predicted molecular weight of
470,695 Da containing 4,322 amino acid residues com-
pared to molecular weights of 90,742, 103,204 and
158,321 Da for the HZ strain VirB6-1, VirB6-2 and
VirB6-3, respectively. Interestingly, the predicted acidity
of the VirB60s also increased from VirB6-1 to VirB6-4
(pI’s of 8.4, 6.8, 5.1 and 4.0 for the ApHZ VirB6-1, VirB6-
2, VirB6-3 and VirB6-4, respectively). The ApDog1/ApJM
VirB6-4 polypeptides had a predicted molecular weight
of 603,529 Da containing 5,550 amino acids, and a pI of
3.96. Despite these dissimilarities, at least eight trans-
membrane segments were predicted for all VirB6
paralogs.
Periplasmic/outer membrane channel subunits: VirB2,
VirB7 and VirB9
Several other T4SS subunits contribute to the secretion
channel across the periplasm and outer membrane.
VirB7 subunits are typically small lipoproteins that may
stabilize VirB9 [38,39]. In A. phagocytophilum strains a
putative VirB7 is absolutely conserved between strains
and may be lipid modified through an N-terminal cyst-
eine on the mature molecule. VirB9 is hydrophilic and
also localizes to the periplasm and outer membrane. In
A. tumefaciens the C-terminal region of VirB9 is part of
the outer membrane protein channel and is surface ac-
cessible [40]. There is also evidence for surface exposure
of VirB9 in Ehrlichia chaffeensis and A. phagocytophilum
[18,19,41]. VirB9-1, which is encoded on the polycistro-
nic virB8-1-virD4 transcript [31], has a strongly pre-
dicted signal peptide and two transmembrane helices. Of
all the potentially exposed components of the T4SS,
VirB9 of A. phagocytophilum appears to be the least di-
verse among strains. There are some amino acid substi-
tutions in ruminant and horse strains (2–6 total
compared to ApHZ) but in the other strains VirB90s are
unchanged (data not shown).
Unlike VirB90s, VirB20s are the most diverse of all
T4SS subunits in A. phagocytophilum, in terms of both
copy number and sequence. VirB2 proteins are typically
constituents of pili and of the secretion channel and
their diversity in Anaplasma suggests the possibility of
exposed, antigenically variable structures. In A. margin-
ale, VirB2 is expressed together with the major outer
Figure 4 Hydrophobicity plots of VirB6-4 proteins from A. phagocytophilum HZ (top) or Dog 1 (bottom) strains.
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cistronic transcript [25,42]. The mechanism of expres-
sion in A. phagocytophilum is not known. VirB20s of
other genera are typically small hydrophobic proteins
with a long signal peptide sequence and two hydropho-
bic alpha helices for integration into the cytoplasmic
membrane. This also appears to be the case for A.phagocytophilum. The VirB2 paralogs in the different
strains are predicted to have two hydrophobic alpha-
helices of lengths 22+/−3 and 20+/−0.2 amino acids and
signal peptides of length 27+/−2 amino acids. This is
true despite their sequence diversity (Figure 5). As with
many other T4SS components, the ruminant and horse
strains are more distant taxonomically in VirB2
Figure 5 Phylogenetic trees to show the relationship of syntenic VirB2 proteins from different strains of A. phagocytophilum.
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strains. Alignment of all VirB2 paralogs and orthologs
shows that sequence diversity is primarily localized to
two hypervariable regions either preceding an N-
terminal cysteine or close to the C-terminus (Figure 6).
This is similar to the hypervariable regions found among
VirB2 paralogs of A. marginale [25].
Energetic subunits: VirB4 and VirB11
ATPases are typically used in T4SS to energize substrate
transfer and have been found in every T4SS described.
In gram-negative bacteria these are typically integral
membrane proteins encoded by genes residing upstream
of virB2 (encoding pilin). This is true for all strains of A.
phagocytophilum and it has been suggested that this ar-
rangement of multiple virB2 paralogs and virB4-2 may
allow assembly of an antigenically variable surface or-
ganelle [20]. The energetic subunit itself, VirB4-2, is
however, well conserved between strains. The most dis-
tant taxonomic relationship was found between human
and ruminant strains (29 total amino acid substitutions
in ApNorLamb-V1 compared to ApHZ, Figure 7). The
other energetic subunit, VirB11, was also well-conservedbetween strains (6 amino acid substitutions between
ApNorLamb-V1 and ApHZ; data not shown).
Type 4 coupling protein: VirD4
Type 4 coupling proteins such as VirD4 are ATPases
that function in substrate recognition and translocation
using the T4SS. They are associated with most effector
translocator systems. They typically possess a minimum
of two N-terminal transmembrane domains. Often most
heterogeneity exists in these N-terminal regions [20].
The A. phagocytophilum VirD40s conform somewhat to
this stereotype with three strongly predicted N-terminal
transmembrane segments. As with the other ATPases of
the A. phagocytophilum T4SS, there is little variation in
VirD4, a total of 17 amino acid substitutions of which 4
are N-terminal but more (12) are C-terminal. Again, the
evolutionary relationships among VirD4 sequences pos-
ition the ruminant and horse strains more distantly to
the U.S. dog, human and rodent strains (Figure 8).
Conclusions
A. phagocytophilum represents a recent reclassification of
intracellular organisms infecting different animal species
ApDog1-VirB2-1               M------------------MSNLTGFVAVLSVIMMF-------GVAGA---IDAC-GVEPTAEKDHTVAVPIK-----GDVAVKSVSGVLQTVRRFCLPVMIGVVSGAVIITVFGRSAWFAIAMLIVFSCIFLGGSEFIQKFTEGVGD-----SAGTKHSRVIASRL------ 
ApHz-VirB2-1                 M------------------MSNLTGFVAVLSVIMMF-------GVAGA---IDAC-GVEPTAEKDHTVAVPIK-----GDVAVKSVSGVLQTVRRFCLPVMIGVVSGAVIITVFGRSAWFAIAMLIVFSCIFLGGSEFIQKFTEGVGD-----SAGTKHSRVIASRL------ 
ApDog2-VirB2-1               M------------------MSNLTGFVAVLSVIMMF-------GVAGA---IDAC-GVEPTAEKDHTVAVPIK-----GDVAVKSVSGVLQTVRRFCLPVMIGVVSGAVIITVFGRSAWFAIAMLIVFSCIFLGGSEFIQKFTEGVGD-----SAGTKHSRVIASRL------ 
ApJM-VirB2-1                 M------------------MSNLTGFVAVLSVIMMF-------GVAGA---IDAC-GVEPTAEKDHTVAVPIK-----GDVAVKSVSGVLQTVRRFCLPVMIGVVSGAVIITVFGRSAWFAIAMLIVFSCIFLGGSEFIQKFTEGVGD-----SAGTKHSRVIASRL------ 
ApVar1-VirB2-1               M------------------MSNLTGFVAVLSVIMMF-------GVAGA---IDAC-GVEPTAEKDHTVAVPIK-----GDVAVKSVSGVLQTVRRFCLPVMIGVVSGAVIITVFGRSAWFAIAMLIVFSCIFLGGSEFIQKFTEGVGD-----SAGTRHSRVIASRL------ 
ApMRK-VirB2-1                I------------------MSNLTGFVAVLSVIMMF-------GVAGA---IDAC-GVEPTAEKDHTVAVPIK-----GDVAVKSVSGVLQTVRRFCLPVMIGVVSGAVIITVFGRSAWFAIAMLIVFSCIFLGGSEFIQKFTEGVGD-----SAGTRHSRVIASRL------ 
ApNorV1-VirB2-1              M------------------MSNLTGFVAVLSVIIMF-------GVAGA---IDAC-GVEPTAEKDHTVAVPIK-----GDVAVKSVSGVLQTVRRFCLPVMIGVVSGAVIITVFGRSAWFAIAMLIVFSCIFLGGSEFIQKFTEGVGD-----SAGTRHSRVIASRL------ 
ApNorV2-VirB2-1              M------------------MSNLTGFVAVLSVIMMF-------GVAGA---IDAC-GVEPTAEKDHTVAVPIK-----GDVAVKSVSGVLETVRRFCLPVMIGVVSGAVIITVFGRSAWFAIAMLIVFSCIFLGGSEFIQKFTEGVGD-----PAGTRHSRVIASRL------ 
ApDog1-VirB2-2               -------------------MFGLTRFMAVLALVVALVGFG-TSAFAS----------------------TTGS-----DDVAAKVICNVVVFVQRLGLPIMTGVILGASIMAIFGKLAWAAIVMLVVFTAIFFGAGKLIQKFAAGVGSDII-GKADSFECKGNGATTLS---- 
ApJM-VirB2-2                 -------------------MFGLTRFMAVLALVVALVGFG-TSAFAS----------------------TTGS-----DDVAAKVICNVVVFVQRLGLPIMTGVILGASIMAIFGKLAWAAIVMLVVFTAIFFGAGKLIQKFAAGVGSDII-GKADSFECKGNGATTLS---- 
ApHz-VirB2-2                 -------------------MFGLTRFMAVLALVVALVGFG-TSAFAS----------------------TTGS-----DDVAAKVICNVVVFVQRLGLPIMTGVILGASIMAIFGKLAWAAIVMLVVFTAIFFGAGKLIQKFAAGVGSDIIGGNAESFECKGNGATTLSS--- 
ApDog2-VirB2-2               -------------------MFGLTRFMAVLALVVALVGFG-TSAFAS----------------------TTGS-----DDVAAKVICNVVVFVQRLGLPIMTGVILGASIMAIFGKLAWAAIVMLVVFTAIFFGAGKLIQKFAAGVGSDIIGGNAESFECKGNGATTLSS--- 
ApVar1-VirB2-2               -------------------MFGLTRFMAVLALVVALVGFG-TSAFANA---STA---------------SAGS-----DDVAAKVICNVVVFVQRLGLPIMTGVILGASIMAIFGKLAWAAIVMLVVFTAIFFGAGKLIQKFAAGVGSDIV-GDTNSFECKGGGGTVLK---- 
ApMRK-VirB2-2                -------------------MFSLTRFMAVLALVVALVGVG-TSDFASA---SAP---------------ATGS-----DDVAAKVICNVVVFVQRLGLPIMTGVILGASIMAIFGKLAWAAIVMLVVFTAIFFGAGKLIQKFAAGVGSDII-GNTDSFECKGGGQTVLGK--- 
ApNorV2-VirB2-2              -------------------MFGLTRFMAVLALVVALVGFG-TSAFAT------A---------------QYAS-----DDVAAKVICNVVVFVQRLGLPIMTGVILGASIMAIFGKLAWAAIVMLVVFTAIFFGAGKLIQKFAAGVGSDII-GDANSFECRGNGETKLGG-SK 
ApNorV1-VirB2-2              -------------------MFGLTRFMAVLALVVALVGFG-TSAFATT---GST---------------QYAS-----DDVAAKVICNVVVFVQRLGLPIMTGVILGASIMAIFGKLAWAAIVMLVVFTAIFFGAGKLIQKFAAGVGSDII-GDANSFECRGNGETKLGGVSK 
ApDog1-VirB2-4               -------------------MAKIVRFFTSTAGMFLLLLLC-SQGVAAG---AS----AN----------DEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIISKFANGVGE----IKANDFDCKEVAEK------- 
ApHz-VirB2-4                 -------------------MAKIVRFFTSTAGMFLLLLLC-SQGVAAG---AS----AN----------DEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIISKFANGVGE----IKANDFDCKEVAEK------- 
ApDog2-VirB2-4               -------------------MAKIVRFFTSTAGMFLLLLLC-SQGVAAG---AS----AN----------DEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIISKFANGVGE----IKANDFDCKEVAEK------- 
ApJM-VirB2-4                 -------------------MAKIVRFFTSTAGMFLLLLLC-SQGVAAG---AS----AN----------DEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIISKFANGVGE----IKANDFDCKEVAEK------- 
ApDog1-VirB2-5               -------------------MAKIVRFFTSTAGMFLLLLLC-SQGVAAD---TA----TN----------EEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFANGVGD----LKATEFDCKEVTK-------- 
ApJM-VirB2-5                 -------------------MAKIVRFFTSTAGMFLLLLLC-SQGVAAD---TA----TN----------EEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFANGVGD----LKATEFDCKEVTK-------- 
ApHz-VirB2-5                 -------------------MAKIVRFFTSTAGMFLLLLLC-SQGVAAG---AS----AN----------DEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFANGVGD----LKATEFDCKEVTK-------- 
ApDog2-VirB2-5               -------------------MAKIVRFFTSTAGMFLLLLLC-SQGVAAG---AS----AN----------DEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFANGVGD----LKATEFDCKEVTK-------- 
ApMRK-VirB2-5                -------------------MAKIVRFFTSTAGMFLLLLLC-SQGVAAG---AS----AN----------DEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFANGVGD----LKATEFDCKEVTK-------- 
ApNorV2-VirB2-5              -------------------MAKVVRFFTSTAGMFLLLLLC-SQGVAAG---AS----AN----------DDHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGVGD----LNANDFDCKTVTG-------- 
ApDog1-VirB2-9               -------------------MAKIVRFFTSTAGMFLLLLLC-SQGVAAG---AS----AN----------DEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGVGE----LNANDFDCKTVTG-------- 
ApJM-VirB2-9                 -------------------MAKIVRFFTSTAGMFLLLLLC-SQGVAAG---AS----AN----------DEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGVGE----LNANDFDCKTVTG-------- 
ApDog2-VirB2-9               -------------------MAKIVRFFTSTAGMFLLLLLC-SHGVAAG---AS----AN----------DEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGVGE----LNANDFDCKTVTG-------- 
ApMRK-VirB2-9                -------------------MAKIVRFFTSTAGMFLLLLLC-SQGVAAG---AS----AN----------AEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGVGE----LNANDFDCKTVTG-------- 
ApMRK-VirB2-4                -------------------MAKIVRFFTSTAGMFLLLLLC-SQGVAAD---TA----TN----------AEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGVGE----LNANDFDCKEVAEK------- 
ApNorV2-VirB2-4              -------------------MAKVVRFFTSTAGMFLLLLLC-SQGVAAG---ASAG-TAN----------EEHK-----KEETSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGVGE----LNANDFDCKSVSDK------- 
ApNorV2-VirB2-9              -------------------MEKIVRFFTNTAGMFLLLLLC-SQGIAVG---VAADQKAN----------EEHK-----KEETSKVICNAVSFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGVGD----LNANDFDCKEVAEK------- 
ApVar1-VirB2-novel2          -------------------MVRIVRFFTSTASMFLLLLLC-SQGVAAG---VSAG-SPS----------VDHK-----NEDTSKVICNVVTFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFANGVGD----LNAKDFDCKSVSNGK------ 
ApNorV1-VirB2-novel1         -------------------MARIVKFLTHTTGMFLLLLLC-SQGVAAG---ASTG-AQS----------AEHK-----NEDTSKVICNVVSFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIISKFANGVGG----VNADGFDCKDVATKP------ 
ApNorV1-VirB2-novel5         -------------------MARIVKFLTHTTGMFLLLLLC-SQGVAAG---ASTG-AQS----------AEHK-----KEDTSKVICNVVMFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAEGVGG----VKGNDFDCKSVSDVK------ 
ApNorV1-VirB2-4              -------------------MVRIVRFFTSTAGMFLLLLLC-SQGVSAG---ASAG-SLD----------DGHK-----NEDTSKVICNVVTFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIISKFANGVGE----IKADGFDCKKVTG-------- 
ApVar1-VirB2-novel6-partial  -------------------MVRIVRFLTRTTGMFLLLLLC-SQGVAAG---ASAD-KAN----------TDHK-----KEDTSKVICNVVTFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKII---------------------------------- 
ApVar1-VirB2-4               -------------------MVRTVRFWTRITGMFLLLLLC-SQGVAAG---------------------AEEH-----KGDTSKVICNVVEFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIISKFANGVGD----LNADKFDCKDVKGEGQHN--- 
ApVar1-VirB2-novel4          -------------------MVKVVRFFTSTAGMFLLLLLC-SQGVAA----DGA---------------KTDH-----DGATSRVICNVVEFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFADGVGN----LDAKGFDCKNVKGDN------ 
ApVar1-VirB2-novel7-partial  --------------------------------------------------------------------------------------------------PIMTGEFLGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFADGVGN----LDAKGFDCKNVKGDN------ 
ApNorV1-VirB2-novel2         -------------------MVRIVRFLARTTGMFLLLLLC-NQGIAS----AVS---------------ADDH-----KGDTSRVICNVVEFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFADGVGN----LNAKGFDCKTVKGDN------ 
ApNorV1-VirB2-novel4         -------------------MARIVKFLTRTTGMFLLLLLC-NQGIAVG---------------------AEEH-----KEDTSKVICNVVGFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFADGVGN----LNAKGFDCKDVKGDK------ 
ApNorV1-VirB2-novel6         -------------------MARIVKFLTRTTGMFLLLLLC-NQGIAVG---------------------AEEH-----KEDTSKVICNVVGFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFADGVGN----LNAKGFDCKTVKGDN------ 
ApNorV1-VirB3-novel3         -------------------MAKVVRFFTSTTWMFLLLLLC-NQGIAGAVSPAVG---------------QGDH-----KGDTSKVICNVVEFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFADGVGN----LNAKGFDCKTVKGDN------ 
ApVar1-VirB2-5               -------------------MEKIVRFLMRTTGMCFLLLLC-SQGVAGA--GAAS---------------TDDH-----KGDTSKVICNVVMFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIISKFANGVGD----LKANDFDCKKVTT-------- 
ApNorV1-VirB2-6              -------------------MEKIVRFLMRTTGMCFLLLLC-SQGVAVA--GAAL---------------ADDH-----KGDTSKVICNVVLFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIISKFANGVGD----LKANDFDCKKVTS-------- 
ApVar1-VirB2-novel5          -------------------MVRIVRFLARTTGMCFLLLLC-SQGVAEP--GTVS---------------AGDH-----KGDTSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIISKFANGVGD----LKADNFDCKTVQGDK------ 
ApVar1-VirB2-novel3          -------------------MVRIVRFLTRTTGMFLLLLLC-SQGVAVASLGGTS---------------TDDH-----KGDTSKVICNVVLFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIISKFANGVGD----LNAEKFDCKDVTKQ------- 
ApNorV1-VirB2-5              -------------------MEKIIRFLMRTTGMCFVLLLC-SHGIVAS--AAAA---------------ATDH-----NGATSKVICNVVEFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIISKFAKGVGG----LDADNFDCSKVKDDASGSSSP 
ApVar1-VirB2-novel1          -------------------MVRIVRFLMRTTGMCFVLLLC-SHGIASA---AAE---------------ATKH-----DGATSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGVGE----LEADNFDCSKVKDDASGSSSL 
ApDog1-VirB2-6               -------------------MAKIVRFFTSTVGMFLLLLLC-SHGIASA---AAA---------------GTDH-----NGVTAKVICNVVLFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGIGE----LDADNFDCSKVQAEESSSV-- 
ApHz-VirB2-6                 -------------------MAKIVRFFTSTVGMFLLLLLC-SHGIASA---AAA---------------GTDH-----NGVTAKVICNVVLFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGIGE----LDADNFDCSKVQAEESSSV-- 
ApDog2-VirB2-6               -------------------MAKIVRFFTSTVGMFLLLLLC-SHGIASA---AAA---------------GTDH-----NGVTAKVICNVVLFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGIGE----LDADNFDCSKVQAEESSSV-- 
ApJM-VirB2-6                 -------------------MAKIVRFFTSTVGMFLLLLLC-SHGIASA---AAA---------------GTDH-----NGVTAKVICNVVLFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGIGE----LDADNFDCSKVQAEESSSV-- 
ApMRK-VirB2-6                -------------------MAKVVRFFTSTVGMFLLLLLC-SNGIASA---AAA---------------ATKH-----DGATSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGIGE----LDADNFDCSKVKAEESNSV-- 
ApNorV2-VirB2-6              -------------------MAKVVRFFTSTVGMFLLLLLC-SHGIASA---AAAV--------------ATKH-----DGATSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGIGE----LDADNFDCSKVKAEESNSVLP 
ApVar1-VirB2-6               -------------------MSKIVRFFTHTTCMFLLLFLC-NQGIAAA---AEA----------------TKH-----DGATSKVICNVVLFAQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAKGIGE----LDADNFDCSKVKAEESNSV-- 
ApDog1-VirB2-7               -------------------MAKVVRFFTSTVGMFLLLLLC-SHGIASA---AAA---------------GTDH-----NGVTAKVICNVVLFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAQGVGE----WEAEKFDCKDIKAG------- 
ApJM-VirB2-7                 -------------------MAKVVRFFTSTVGMFLLLLLC-SHGIASA---AAA---------------GTDH-----NGVTAKVICNVVLFVQKLGLPIMTGVILGSSVMAIFGRLAWPAIAMLIVFTAIFFGSSKIIGKFAQGVGE----WEAEKFDCKDIKAG------- 
ApHz-VirB2-7                 -------------------MAKVVRFFTSTVGMFLLLLLC-SHGIASA---AAA---------------GTDH-----NGVTAKVICNVVLFVQKLGLPIMTGVILGSSVMAIFGRLAWPSIAMLIVFTAIFFGSSKIIGKFAQGVGE----WEAEKFDCKDIKAG------- 
ApDog2-VirB2-7               -------------------MAKVVRFFTSTVGMFLLLLLC-SHGIASA---AAA---------------GTDH-----NGVTAKVICNVVLFVQKLGLPIMTGVILGSSVMAIFGRLAWPSIAMLIVFTAIFFGSSKIIGKFAQGVGE----WEAEKFDCKDIKAG------- 
ApMRK-VirB2-7                -------------------MAKVVRFFTSTVGMFLLLLLC-SNGIASA---AAA---------------GTDH-----NGVTAKVICNVVLFVQKLGLPIMTGVILGSSVMAIFGRLAWPSIAMLIVFTAIFFGSSKIIGKFAQGVGE----WEAEKFDCKDIKAG------- 
ApVar1-VirB2-7               -------------------MAKVVRFLTGTVGMFLLLLLC-SHGIASA---AAA---------------GTDH-----NGVTAKVICNVVIFIQKLGLPIMTGVIMGSSIMAIFGRLAWPSIAMLIVFTAIFFGSSKIIGKFAQGVGE----WEAEKFDCKDIKAG------- 
ApNorV2-VirB2-7              -------------------MGRIVRFLTRTVGMFLLLLLC-SQGIASA---AAA---------------DTDH-----SGVTAKVICNVVLFVQKLGLPIMTGVILGSSVMAIFGRLAWPSIAMLIVFTAIFFGSSKIIGKFAQGVGE----WEAEKFDCKDIKAG------- 
ApNorV1-VirB2-7              -------------------MAKIVKFFMHTTCMFLLLFFC-NQGIAAA---AT----------------HIEP-----KDPISRVICNVVIFIQKLGLPIMTGVIMGSSIMAIFGRLAWHTIATLVVFTAIFFGAGKIISKIASGIGG----LNAEKFDCKPGKAKKQEIWII 
ApDog1-VirB2-8               M------------------FTNILRSCVISIIFFIFLILP-AVSVSAA---PVAH--------------AAGD-----GEVISKVICNVVVFVQRLGLPIMTGVILGSSIMAVFGRLAWPAIVMLVVFTAIFFGAGKLISKFAGGISE----LGAEDFDCRVLAGKNI----- 
ApDog2-VirB2-8               M------------------FTNILRSCVISIIFFIFLILP-AVSVSAA---PVAH--------------AAGD-----GEVISKVICNVVVFVQRLGLPIMTGVILGSSIMAVFGRLAWPAIVMLVVFTAIFFGAGKLISKFAGGISE----LGAEDFDCRVLAGKNI----- 
ApJM-VirB2-8                 M------------------FTNILRSCVISIIFFIFLILP-AVSVSAA---PVAH--------------AAGD-----GEVISKVICNVVVFVQRLGLPIMTGVILGSSIMAVFGRLAWPAIVMLVVFTAIFFGAGKLISKFAGGISE----LGAEDFDCRVLAGKNI----- 
ApMRK-VirB2-8                M------------------FTNILRSCVISIIFFIFLILP-AVSVSAA---PVAH--------------AAGD-----GEVISKVICNVVVFVQRLGLPIMTGVILGSSIMAVFGRLAWPAIVMLVVFTAIFFGAGKLISKFAGGISE----LGAEDFDCRVLAGKNI----- 
ApNorV2-VirB2-8              M------------------FTNILRSCVISIIFFIFLILP-AVSVSAA---PVAH--------------AAGD-----GEVISKVICNVVVFVQRLGLPIMTGVILGSSIMAVFGRLAWPAIVMLVVFTAIFFGAGKLISKFAGGISE----LGAEDFDCRVLAGKNI----- 
ApNorV1-VirB2-8              M------------------FTNILRSCVISIIFFIFLILP-AVSVSAA---PVAH--------------AAGD-----GEVISKVICNVVVFVQKLGLPIMTGVILGSSIMAVFGRLAWPAIVMLVVFTAIFFGAGKLISKFAGGISE----LGAEDFDCRVLAGKNI----- 
ApVar1-VirB2-8               M------------------FTNILRSCVISMIFFIFLILP-AVSVSAA---PVAH--------------AAGD-----GEVISKVICNVVVFVQKLGLPIMTGVILGSSIMAVFGRLAWPAIVMLVVFTAIFFGAGKLISKFAGGISE----LGAEDFDCRVLAGKNI----- 
ApHz-VirB2-8                 M------------------FTNILRSCVISIIFFIFLILP-AVSVSAA---PVTH--------------AAGD-----GEVISKVICNVVVFVQRLGLPIMTGVILGSSIMAVFGRLAWPAIVMLVVFTAIFFGAGKLISKFAGGISE----LGAEDFDCRVLAGKNI----- 
ApDog1-VirB2-3               MDTQGRAIAEDRRSFARTFFNKKVFFLIIQGSLFFVLLLILDEAYAGV---AESN-LFPAVAQHG----SATN-----EDVTSKVICNVVKFVRGIGLPIMTGVILGSSVMAIFGRLAWPAIAALVIFTAVFFGAEKVISKFTDGISV----MQTGNCDTI------------ 
ApHz-VirB2-3                 MDTQGRAIAEDRRSFARTFFNKKVFFLIIQGSLFFVLLLILDEAYAGV---AESN-LFPAVAQHG----SATN-----EDVTSKVICNVVKFVRGIGLPIMTGVILGSSVMAIFGRLAWPAIAALVIFTAVFFGAEKVISKFTDGISV----MQTGNCDTI------------ 
ApDog2-VirB2-3               MDTQGRAIAEDRRSFARTFFNKKVFFLIIQGSLFFVLLLILDEAYAGV---AESN-LFPAVAQHG----SATN-----EDVTSKVICNVVKFVRGIGLPIMTGVILGSSVMAIFGRLAWPAIAALVIFTAVFFGAEKVISKFTDGISV----MQTGNCDTI------------ 
ApJM-VirB2-3                 MDTQGRAIAEDRRSFARTFFNKKVFFLIIQGSLFFVLLLILDEAYAGV---AESN-LFPAVAQHG----SATN-----EDVTSKVICNVVKFVRGIGLPIMTGVILGSSVMAIFGRLAWPAIAALVIFTAVFFGAEKVISKFTDGISV----MQTGNCDTI------------ 
ApMRK-VirB2-3                MDTQGRAIAEDRRSFARTFFNKKVFFLIIQGSLFFVLLLILDEAYAGV---AESN-LFPAVAQHG----SATN-----EDVTSKVICNVVKFVRGIGLPIMTGVILGSSVMAIFGRLAWPAIAALVIFTAVFFGAEKVISKFTDGISG----MQTGNCDTI------------ 
ApNorV2-VirB2-3              MDTQGRAMAEDRRSFARTFFNKKVFFLIIQGSLFFVLLLILDEAYAGV---AESN-LFPAVAQHG----SATN-----EDVTSKVICNVVKFVRGIGLPIMTGVILGSSVMAIFGRLAWPAIAALVIFTAVFFGAEKVISKFTDGISG----MQTGNCDTI------------ 
ApNorV1-VirB2-3              MDTQGRAMAEDRRSFARTFFNKKVFFLIIQGSLFFVLLLILDEAHAGV---AESN-LFPAVAQHG----SAAN-----EDVTSKVICNVVKFVRSIGLPIMTGVILGSSVMAIFGRLAWPAIAALVIFTAVFFGAEKVISKFTDGISG----MQTGNCDTI------------ 
ApVar1-VirB2-3               MNTQGRAMAEDRRSFARTFFNKKVFFLIIQGSLFFVLLLILDEAHAGV---SESN-LFPAVAQHG----SAANEDVTSEDVTSKVICNVVKFVRSIGLPIMTGVILGSSVMAIFGRLAWPAIAALVIFTAVFFGAEKVISKFTDGISG----MQTGNCDTI------------ 
Consensus/80%                ...................bsplsbFhs..shbbbblhb..s.thAts.....................s..p........stKVICNVV.Fsp+lGLPIMTGVILGSSlMAIFGRLAWsAIAMLlVFTAIFFGttKlI.KFs.Gltp....hpA.sb-sp.h.......... 
Figure 6 Multiple sequence alignment of VirB2 amino acid sequences from different strains of A. phagocytophilum.
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http://www.biomedcentral.com/1471-2164/13/678and humans and causing diverse disease symptomatology
[43]. These bacteria were previously known as Ehrlichia
phagocytophila, Ehrlichia equi, and the agent of human
granulocytic ehrlichiosis. Despite the differences within
this species, the overall genome structure and synteny of
the T4SS is maintained. However, gene structural analysis
reveals evidence of gene duplication and considerable di-
versity of T4SS components in strains infecting different
animals. Taxonomic trees suggest a close evolutionary re-
lationship of A. phagocytophilum strains infecting U.S.
humans, mice and dogs and a more distant relationship
with ruminant and horse strains. This relationship is not
unique to the T4SS but is also supported by similar taxo-
nomic trees of other A. phagocytophilum proteins of con-
served metabolic function (Figure 9). Within the T4SS
multicomponent membrane complex, the energetic and
internal scaffolding protein components are the most con-
served. In contrast, components that form the proposed
exposed structures of the T4SS, such as VirB2 and VirB6,
are more variable. T4SS are important virulencedeterminants of bacteria, therefore these differences may
result in the different infectivity and virulence profiles
observed with different strains. It will be of interest to de-
termine the molecular architecture of VirB6 paralogs in
different strains, including interactions with other T4SS
components and effectors. Of the known surface exposed
components of the T4SS, VirB9 is the most conserved.
This protein has been proposed as a vaccine component
against A. marginale and may also be suitable against
A. phagocytophilum.
Methods
A. phagocytophilum strains, cell culture, and experimental
infection
The A. phagocytophilum U.S. strains HZ (human-origin,
NY), MRK (horse-origin, CA), JM (rodent-origin, MN)
and Dog1 (dog-origin, MN) were propagated in HL-60
cells in RPMI-1640 medium (Thermo Fisher Scientific,
Inc., Waltham, MA) supplemented with final 10% heat-
inactivated fetal bovine serum (Thermo Scientific) and
Figure 7 Phylogenetic trees to show the relationship of syntenic VirB4 proteins from different strains of A. phagocytophilum.
Figure 8 Phylogenetic tree to show the relationship of syntenic
VirD4 proteins from different strains of A. phagocytophilum.
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absence of antibiotics. ApHZ and ApMRK have been
described previously [15,44]. The ApJM strain (CR01-
1258) originated from a meadow jumping mouse (Zapus
hudsonius) trapped at Camp Ripley, MN [45]. The
ApDog1 strain originated from the blood of a dog from
Baxter, MN naturally infected with A. phagocytophilum,
as evidenced by the detection of distinctive morulae in a
diagnostic blood sample, and sequencing of the Expres-
sion Site-linked msp2/p44 gene. Briefly, whole blood was
collected from the animal with EDTA as an anticoagu-
lant. The buffy coat layer was collected after low-speed
centrifugation of the whole-blood, washed in 1x phos-
phate buffered saline (PBS, Hyclone, cat. no. SH30256.01),
then added to a culture of uninfected HL-60 cells. The
culture was left undisturbed for 3 days, after which mor-
ulae began to appear. The ApDog2 strain also originated
from a MN dog and was passaged to and maintained in
the Ixodes scapularis ISE6 tick cell line as described [46].
The Ap variant 1 CRT35 strain (tick-origin, MN),
maintained in ISE6 cells, has been described [47]. For
DNA isolation, cultures were maintained until 90-100%
of cells were infected with mature morulae. Cells were
pelleted by centrifugation at 2500 x g for 20 min at 4°C.
Pellets were gently resuspended in 1.5 ml cold PBS, trans-
ferred to screw-cap microfuge tubes, and centrifuged at
Figure 9 Phylogenetic tree to show the relationship of other conserved proteins from different strains of A. phagocytophilum. These
proteins are: PolA, DNA polymerase I; LeuS, leucyl-tRNA synthetase; AtpA, ATPsynthase F1, alpha subunit; ValS,valyl-tRNA synthetase; RecG,
ATP-dependent DNA helicase; LigA, NAD-dependent DNA ligase.
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and the cell pellets stored at −80°C until further use.
Two naturally occurring Norwegian lamb A. phagocy-
tophilum strains differing in the 16S rRNA gene and de-
gree of virulence were used to experimentally infect
lambs raised in an indoor environment with barriers
against tick entry and tick infestation. Lamb 00186 was
infected with the more virulent variant 1 (identical to
GenBank M73220) and lamb 0054 with variant 2 (identi-
cal to GenBank AF336220) [48], to be referred to as
ApNorLamb-V1 and -V2 from here on. Infections were
monitored by microscopy and blood was harvested at
maximum parasitemia. To purify buffy coats containing
the infected neutrophils, approximately 2.5 l of Na-
citrated blood was collected from each animal. Theblood was transferred to 1 l centrifuge bottles and cen-
trifuged at 2,500-3,000 x g in a swing-out bucket rotor
for 30 min at 4°C. After removing most of the plasma
layer, the buffy coat layer was collected with minimal
contamination of red blood cells. The cells were diluted
1:3 with PBS, mixed gently and centrifuged at 1,500x g
for 20 min at 4°C. Following three PBS washes, superna-
tants were removed and the cell pellets stored at −80°C.
The experimental study in sheep was approved by the
Norwegian Animal Research Authority.
Purification of host cell-free A. phagocytophilum and
genomic DNA (gDNA) isolation
For the HZ, JM, Dog1, MRK and NorLamb-V1 and -V2
strains, intact, host cell-free organisms with minimal
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frozen PBS pellets of infected cells prepared as above.
Samples and reagents were maintained on ice through-
out the entire procedure, and all centrifugations per-
formed at 4°C. Following a quick thaw, host cells were
disrupted by vigorous vortexing for 5 min. An equal vol-
ume of PBS was added and vortexing continued for
3 min. Cellular debris was removed by centrifugation at
200 x g for 15 min. After removing most of the superna-
tants to fresh tubes, these were passed several times
through a 31 G needle and saved on ice. Pellets were
resuspended well in final 500 μl PBS then passed serially
through 22 G, 25 G, 28 G and, when possible, 31 G nee-
dles attached to a 1 ml syringe. 3–5 volumes PBS were
added and mixed by vortexing. Debris was removed by
centrifugation at 200 x g for 10 min. Supernatants were
pooled to those from the previous centrifugation step.
RNaseA was added to a final 250–300 μg/ml and the
samples incubated 45–60 min at 37°C. Samples were
centrifuged at 21,000 x g for 30 min and the superna-
tants removed completely. Pellets were resuspended in
50–100 μl PBS each and transferred to fresh tubes. To
ensure homogeneity of the suspension, initially a drawn-
out 10 μl pipette tip was used to disrupt the pellet by
swirling followed by up/down pipetting and gentle vor-
texing, before switching to a larger tip. The sample was
further homogenized by several passes through a 28-
31 G needle. PBS was added to final 500–700 μl and
DNaseI to final 250 μg/ml. Following 45–60 min incuba-
tion at 37°C the samples were centrifuged at 21,000 x g
for 30 min. Pellets were homogenized as above and the
DNaseI treatment repeated. EDTA (pH 8.0) was added
to final 25 mM and the samples centrifuged as above.
Tubes were washed twice with PBS without disturbing
the pellets and residual PBS was removed after 3 min
centrifugation at 21,000 x g. Pellets were homogenized
as above in 600–800 μl RPMI culture medium (contain-
ing 10% fetal bovine serum) added incrementally and
transferred to a 50 ml tube. Culture medium was added
to a final volume of 6 ml before passage through a pre-
wet, 2 μm pore-size, 25 mm, GMF-150 glass microfiber
syringe filter (Puradisc 25GD; Whatman Inc., Florham
Park, NJ). The filter was washed 3-4x with culture
medium. Washes were pooled to the filtrate and centri-
fuged at 22,000 x g for 30 min. The pellets, comprised of
free, non-viable organisms and host cell mitochondria,
were resuspended in PBS, transferred to microfuge tubes
and re-pelleted at 21,000 x g for 30 min. Supernatants
were removed completely and the pellets were processed
immediately or stored at −20°C. For every 108 host cells
used at 90-100% infectivity, enough organisms were
recovered to yield on average 1–1.5 μg high-quality
DNA using either the Gentra Puregene Yeast/Bact. kit
(Qiagen Inc., Valencia, CA) or the QIAGEN Blood &Cell Culture DNA mini kit following the manufacturer’s
protocols.
For the Dog2 and Ap variant 1 strains, organisms were
cultured and isolated from ISE6 tick cells as described
[49]. Host cell-free bacteria were prepared from two cul-
tures in 25 cm2 flasks, collected by centrifugation for
10 min at 11,000 xg at 4°C, and lysed in Gentra Pure-
gene lysis buffer (Qiagen) at 80°C for 5 min. Since these
DNA samples also contained a considerable amount of
small (<500 bp) DNA species naturally associated with
the ISE6 host cell line, the A. phagocytophilum gDNA
was further purified by electroelution from agarose gels,
followed by phenol/chloroform extraction and EtOH
precipitation using conventional protocols.
Preparation of host cell-free A. phagocytophilum agarose
plugs for optical mapping
ApDog1 was initially selected for complete genome se-
quencing to compare with the published HZ strain.
When a draft genome was assembled for ApDog1 it was
largely syntenic with HZ except for the virB6 locus, indi-
cating a possible error in the sequence of one or both of
the strains. Accordingly, the ApDog1 draft genome se-
quence was verified by Optical Mapping. In preparation
for Optical Mapping (performed by OpGen Inc.,
Gaithersburg, MD), host cell-free organisms were em-
bedded in 0.5% low-melting point agarose plugs and
subsequently lysed, allowing access to the intact,
~1.48 Mb circular A. phagocytophilum chromosome. A
procedure recommended by OpGen was followed. All
solutions were made fresh using OpGen suggested
reagents. Intact ApDog1 organisms were purified as
above, except that the pellet of free organisms obtained
following centrifugation of the filtrate was resupended
and washed in cell suspension buffer [200 mM NaCl,
100 mM EDTA-Na2 (pH 8.0), 10 mM Tris (pH 7.2)].
Plugs were made immediately on completion of the iso-
lation procedure. Briefly, following the final centrifuga-
tion of the purified organisms, the pellet was
resuspended in cell suspension buffer using 40–50 μl for
every 108 host cells used at >95% infectivity. The sample
was passed 2x through a 31 G needle (3/10 ml capacity
Insulin Syringe with fused 8 mm long needle, BD
#328438; Becton, Dickinson & Co., Franklin Lakes, NJ)
to ensure homogeneity of the thick suspension, and an
equal volume of 1% low melting point SeaPlaque GTG
agarose [(Lonza #50111) dissolved in DEPC-treated
water (Invitrogen #750023; Carlsbad, CA) and held at 55°C]
was immediately added. Following mixing, 100 μl aliquots
were dispensed into plug molds (Bio-Rad #170-3713;
Hercules, CA) and allowed to set for 1 hr at 4°C prior to
transfer into a 50 ml tube containing 5–10 ml, 50°C NDSK
solution [filter sterile NDS solution (1% N-lauroylsarcosine
(Sigma #L5000; St. Louis, MO) in 0.5 M EDTA-Na2
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K (Pierce #17916; Rockford, IL) immediately prior to
use]. The tube was incubated upright at 50°C with
mild shaking (40 rpm) for 8–24 hrs, until the plugs
turned clear and colorless. Plugs were gently washed
3x in 5 ml 0.5 M EDTA-Na2 (pH 9.5), then transferred
to a fresh tube and stored in EDTA at 4°C. Optical
Mapping data generated from the BamHI-digested
ApDog1 chromosome was analyzed using the OpGen
MapSolver software.
454 Genome sequencing and bioinformatics
Isolated DNA was provided to the Interdisciplinary Cen-
ter for Biotechnology Research (ICBR) core facilities,
University of Florida for library construction and pyrose-
quencing on the Roche/454 Genome Sequencer accord-
ing to standard manufacturer protocols. Regular read
libraries were generated for all strains. Additionally, 3 kb
paired end libraries were made for ApHZ, ApDog1 and
ApMRK. Genome coverage range was 31.3x to 72.1x.
For each strain, the SFF format flow files, returned by
ICBR for bioinformatics analysis, were first combined
and converted to .fasta and .qual files (or the two com-
bined in .fastq format) using Roche/454 Genome Se-
quencer FLX System software. Genome drafts were
assembled using the CLC Genomics Workbench soft-
ware suite (version 4.0-4.9) by mapping reads initially
against the fully annotated, Sanger sequenced ApHZ
genome (GenBank CP000235), then against the com-
pleted ApDog1 genome. Default parameters were used:
length fraction, 0.5; similarity, 0.8; and for paired end
reads, minimum distance, 1500/maximum distance,
4500. To obtain the vir loci, the resulting consensus se-
quence and underlying aligned reads were inspected for
conflicts and mismatched paired ends suggesting the
presence of insertions and/or deletions not mirrored in
the consensus. These were manually corrected. Gaps
were also manually closed where possible. Briefly, over-
lapping reads covering at least 2 kb of sequence on both
sides of a gap and extending into it were individually
extracted from the alignment. A new consensus for each
side was obtained by assembling the reads against each
other, and 250 N’s were added to its ends. These were
individually used as the reference sequence against
which all the 454 reads were re-mapped to pull out
novel reads extending into the unknown region. The
process was repeated multiple times, allowing for the in-
cremental filling of the gap. PCR, followed by sequen-
cing was performed when sequences extrapolated in this
fashion spanned complex tandem repeat regions such as
repeat regions 1 and 3 (R1 and R3 in Figure 3A) of the
virB6-4 gene, or when gap closure could not be com-
pleted due to such structures, as was the case with the
extremely long virB6-4 R4 (Figure 3A) region.Amino acid sequences were aligned with MAFFT [50]
and displayed with CHROMA [51]. Taxonomic relation-
ships used a neighbor-joining tree and the ITT substitu-
tion model [52] and were displayed using Archaeopteryx
(http://www.phylosoft.org/archaeopteryx). Hydrophobicity
analyses were conducted using the method of Hopp and
Woods [53,54] at web.expasy.org and transmembrane seg-
ments were predicted with TMpred at http://www.ch.
embnet.org/software/TMPRED_form.html.
PCR amplification of virB6-4 gene repeat regions, cloning,
and Pacific Biosciences sequencing
Due to difficulties in amplifying tandem repeat-containing
DNA, all PCR reactions spanning the virB6-4 gene repeat
regions were performed in the presence of 1.5-1.7 M
Betaine (Sigma). The 8.36 kb PCR product spanning R3
and R4 in the ApHZ strain (Figure 3A, 3C, and Additional
file 2: Figure S2A) was amplified using the iProof
High-Fidelity DNA Polymerase system with GC buffer
(Bio-Rad). Reactions totaled 50 μl with 5 ng purified A.
phagocytophilum gDNA, 1.0 U polymerase, 1.5 mMMgCl2,
200 μM each dNTP, and 250 nM each primer (AB1393:
50-CGGGATCTAAGACAGATGATGATTC-30, forward;
AB1466: 50-CTCATCCTGATGCGTCTCCTTAG-30, re-
verse; Figure 3A). 35 cycles of 30 sec denaturing at 98°C,
20 sec annealing at 67°C, and 5 min extension at 72°C were
performed. PCR products spanning R4 in ApJM and
ApDog1 (both ~10.3 kb; Figure 3C) were derived using
Takara’s PrimeSTAR GXL DNA Polymerase system (Clon-
tech Laboratories, Mountain View, CA). Reactions con-
tained 5 ng gDNA, 1.25 U polymerase, 1.0 mM MgCl2,
200 μM each dNTP, and 200 nM each primer (AB1395: 50-
CACCAGAGGATGCAGCATTAG-30, forward; AB1466,
reverse; Figure 3A) in total 50 μl. Following the manufac-
turer’s recommendations, 2-step PCR was performed with
30 cycles of 10 sec denaturing at 98°C and 10 min anneal-
ing/extension at 68°C. PCR products were analyzed on
0.5% agarose gels alongside the 1 kb Plus (Invitrogen) and
the GeneRulerHighRange (Fermentas, Inc., Glen Burnie,
MD) DNA ladders. In order to TA-clone the amplicons, A-
overhangs were added to the ends using 0.5-1.0 units
AmpliTaq DNA polymerase (Applied Biosystems, Foster
City, CA) in a 10–15 min reaction at 72°C. Products puri-
fied from agarose gels (before or after A-overhang addition)
were cloned into the pCR-XL-TOPO vector (Invitrogen)
and transformed into E. coli Stbl2 (Invitrogen), which is
more permissive to repeat-laden foreign DNA. Recombi-
nants containing the correct size insert were end sequenced
to verify their identity.
In preparation for sequencing with the long-read
length Pacific Biosciences (PacBio) next-generation se-
quencing RS instrument, constructs were linearized with
restriction enzymes which cut the vector only, but on
opposite sides of the insert within the Multiple Cloning
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were cut with either HindIII or EcoRV. Following pool-
ing and EtOH precipitation, the linearized DNA mix
was submitted to ICBR/UF for SMRTbell library con-
struction and sequencing. Libraries were constructed
using a commercial strobe library preparation kit
(#001-326-530; Pacific Biosciences, Menlo Park, CA)
following standard manufacturer protocols. To further
increase the likelihood of full coverage, the strobe-
sequencing run was performed using two different
conditions: I) 45 min light period (continuous collec-
tion time); and II) (5 min light period, 10 min dark
period), followed by (45 min light period, 10 min dark
period). The ApJM and ApDog1 constructs were
double-digested with HindIII/XbaI to excise the ~10.3 kb
inserts. Following separation on 0.5% agarose gels, the
inserts were recovered from agarose slices by electroelu-
tion and further purified and concentrated by passage
over QIAquick spin columns following the PCR Purifica-
tion kit protocol (Qiagen). SMRTbell libraries were made
as above then sequenced using a single 75 min movie
time run.
Due to the repetitive nature of the cloned gene frag-
ments, combined with the relatively high error-rate of
the PacBio system, all attempts to assemble the reads de
novo failed to yield a sequence of the expected size.
Therefore, for each construct, reads >3 kb were selected
from the multi-fasta files using the Galaxy suite [55],
and imported into the CLC Genomics Workbench for
assembly and further analysis. These were assembled at
low stringency initially against a consensus sequence
representing an entire (vector and insert sequence) lin-
ear construct to which sufficient N’s were added based
on the estimated gap-size. Starting with reads initiating
outside the repeat region, the longest of the assembled
reads were visually inspected for the presence of virB6-4
R4 repeat signature-sequences (Additional file 2: Figure
S2) and their sequence manually corrected where neces-
sary. The extended sequences were used to replace N’s
in the consensus and the process repeated several times
until sufficient reads with >2 kb sequence overlap were
recovered spanning the entire insert region. For verifica-
tion, the completed sequence for each strain was used as
the reference to re-map all the respective >3 kb PacBio
reads and the Roche/454 reads at higher stringency.
GenBank Accession Numbers: for each isolate, the vir
genes are listed in order
The sequences of vir loci are complete for strains
ApDog1 and ApJM. The sequence of the repetitive
virB6-4 locus was incomplete (ApDog2) or not deter-
mined for the other strains except ApHz. We provide a
revised sequence of virB6-4 for the previously sequenced
[15] ApHZ strain.ApDog1:JX415845 - JX415868
B2-1 B2-2, B2-3, B2-4, B2-5, B2-6, B2-7, B2-8, B2-9,
B3, B4-1, B4-t1, B4-2, B6-1, B6-2, B6-3, B6-4, B8-1, B8-
2, B9-1, B9-2, B10, B11, D4
ApJM:JX415869 - JX415892
B2-1, B2-2, B2-3, B2-4, B2-5, B2-6, B2-7, B2-8, B2-9,
B3, B4-1, B4-t1, B4-2, B6-1, B6-2, B6-3, B6-4, B8-1, B8-
2, B9-1, B9-2, B10, B11, D4
ApDog2:JX415893 - JX415915 (virB6-4 submitted
separately as gapped)
B2-1, B2-2, B2-3, B2-4, B2-5, B2-6, B2-7, B2-8, B2-9,
B3, B4-1, B4-t1, B4-2, B6-1, B6-2, B6-3, B8-1, B8-2, B9-
1, B9-2, B10, B11, D4
ApNorLambV2:JX415916 - JX415938
B2-1, B2-2, B2-3, B2-4, B2-5, B2-6, B2-7, B2-8, B2-9,
B3, B4-1, B4-t1, B4-2, B6-1, B6-2, B6-3, B8-1, B8-2, B9-
1, B9-2, B10, B11, D4
ApNorLambV1:JX415939 - JX415966
B2-1, B2-2, B2-3, B2-4, B2-5, B2-6, B2-7, B2-8, B2-
novel1, B2- novel2, B2-novel3, B2-novel4, B2-novel5,
B2-novel6, B3, B4-1, B4- t1, B4-2, B6-1, B6-2, B6-3, B8-
1, B8-2, B9-1, B9-2, B10, B11, D4
ApHZvirB6-4:JX415967
ApVar1:JX415968 - JX415996
B2-1, B2-2, B2-3, B2-4, B2-5, B2-6, B2-7, B2-8, B2-
novel1, B2- novel2, B2-novel3, B2-novel4, B2-novel5,
B2-novel6, B2-novel7, B3, B4-1, B4-t1, B4-2, B6-1,
B6-2, B6-3, B8-1, B8-2, B9-1, B9-2, B10, B11, D4
ApMRK:JX415997 - JX416019
B2-1, B2-2, B2-3, B2-4, B2-5, B2-6, B2-7, B2-8, B2-9,
B3, B4-1, B4-t1, B4-2, B6-1, B6-2, B6-3, B8-1, B8-2, B9-
1, B9-2, B10, B11, D4
ApDog2virB6-4Gapped:JX416020.
Additional files
Additional file 1: Figure S1. Multiple sequence alignment of
VirB6-3 amino acid sequences from different strains of A.
phagocytophilum. Arrows indicate the locations of C-terminal 41-mer
repeats.
Additional file 2: Figure S2. Structure of the virB6-4 repeat regions R3
and R4 in four US A.phagocytophilum strains.A. Comparative maps of
AB1393/AB1466 PCR products detailing the repeat unit content of R3 and
R4 in the human, rodent and dog strains. ApJM and ApDog1 have
identical virB6-4 genes and are, therefore, represented by one map.
Moderate variability in the number and sequence of the R3 405 bp
repeat units (light blue arrows) is apparent. The small bar at the end of
R3 corresponds to the 30-most partial repeat unit present in all strains.
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http://www.biomedcentral.com/1471-2164/13/678The colored arrows within R4 represent the five repeat types T1a (yellow),
T1b (green), T2a, (red), T2b (dark blue) and T2c (grey). The repeat pattern
in ApHZ shows no relationship to that of ApJM/ApDog1, which is also
2.87 kb larger, totaling 9.76 kb. This region was not fully characterized in
ApDog2 as indicated by a broken line, but the repeat pattern of the 50-
and 30-most repeats is clearly different from that of the other strains. The
small bar downstream of the second repeat unit represents a partially
characterized type 2 repeat unit. Lines above and below the ApHZ and
ApJM/ApDog1 maps delineate segments of sequence identity within the
respective R4 regions. Their sizes are specified. B. Alignment of the
nucleic acid sequence of all virB6-4 R4 repeat unit types identified to
date. Type 1 repeats are shown in black, type 2 in blue. Differences
between sub-types are highlighted. A single BamHI site present in all
type 2 repeats is underlined. With the exception of only a few
nucleotides at each end, type 1 and type 2 repeat units do not share any
sequences. C. Alignment of the amino acid sequences of the repeat units
shown in B. The single nucleotide differences between sub-types do not
lead to changes in amino acid sequence.Competing interests
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